Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.67
-0.26 (-3.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Adicet Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 82 | 85 | 87 | 82 | 383 | 685 | |
| Market Cap Growth | 68.47% | -2.63% | 7.13% | -78.70% | -44.04% | 148.60% | |
| Enterprise Value | -61 | -2 | -96 | -80 | 122 | 513 | |
| Last Close Price | 7.67 | 8.42 | 15.39 | 30.24 | 143.04 | 279.84 | |
| PS Ratio | - | - | - | - | 15.33 | 70.36 | |
| PB Ratio | 0.52 | 0.53 | 0.47 | 0.48 | 1.31 | 2.26 | |
| P/TBV Ratio | 0.52 | 0.53 | 0.47 | 0.48 | 1.40 | 2.41 | |
| EV/Sales Ratio | - | - | - | - | 4.89 | 52.72 | |
| Debt / Equity Ratio | 0.09 | 0.09 | 0.09 | 0.12 | 0.07 | 0.07 | |
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.85 | -0.82 | -0.81 | -0.85 | |
| Net Debt / EBITDA Ratio | 1.24 | 1.24 | 1.31 | 1.10 | 3.38 | 4.37 | |
| Net Debt / FCF Ratio | 1.48 | 1.48 | 1.70 | 1.41 | 3.85 | 4.00 | |
| Asset Turnover | - | - | - | - | 0.08 | 0.04 | |
| Quick Ratio | 7.38 | 7.38 | 9.10 | 8.28 | 13.10 | 17.02 | |
| Current Ratio | 7.47 | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 | |
| Return on Equity (ROE) | -67.55% | -67.55% | -65.65% | -61.69% | -23.44% | -30.03% | |
| Return on Assets (ROA) | -37.00% | -37.00% | -37.31% | -30.80% | -13.54% | -15.28% | |
| Return on Capital Employed (ROCE) | -71.50% | -71.50% | -63.50% | -70.50% | -23.30% | -18.70% | |
| Earnings Yield | -141.67% | -137.26% | -134.02% | -174.87% | -18.22% | -9.06% | |
| FCF Yield | -117.63% | -113.97% | -106.98% | -120.35% | -16.07% | -9.36% | |
| Buyback Yield / Dilution | -25.49% | -25.49% | -104.14% | -4.78% | -32.72% | -322.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.